Gilead Sciences (GILD) PT Raised to $175 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $125.93 +0.85%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Gilead Sciences (NASDAQ: GILD) to $175.00 (from $171.00) while maintaining a Overweight rating.
You May Also Be Interested In
- EU approves Gilead's Trodelvy for first-line metastatic TNBC
- American Airlines (AAL) PT Raised to $21 at UBS Ahead of Q2 Earnings
- Cytokinetics (CYTK) PT Raised to $118 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
